Patent 7101967 was granted and assigned to Cyclacel Limited on September, 2006 by the United States Patent and Trademark Office.
The invention relates to modified and truncated forms of the membrane transport vector penetratin. Such truncated forms include 7-mer peptides that may in themselves include further variation.